591 related articles for article (PubMed ID: 8621775)
21. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.
Martin SR; Emanuel K; Sears CE; Zhang YH; Casadei B
Cardiovasc Res; 2006 Apr; 70(1):97-106. PubMed ID: 16545353
[TBL] [Abstract][Full Text] [Related]
22. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate.
Ririe DG; Butterworth JF; Royster RL; MacGregor DA; Zaloga GP
Anesthesiology; 1995 Apr; 82(4):1004-12. PubMed ID: 7717535
[TBL] [Abstract][Full Text] [Related]
23. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes.
Belhassen L; Feron O; Kaye DM; Michel T; Kelly RA
J Biol Chem; 1997 Apr; 272(17):11198-204. PubMed ID: 9111020
[TBL] [Abstract][Full Text] [Related]
24. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.
Massion PB; Dessy C; Desjardins F; Pelat M; Havaux X; Belge C; Moulin P; Guiot Y; Feron O; Janssens S; Balligand JL
Circulation; 2004 Oct; 110(17):2666-72. PubMed ID: 15492314
[TBL] [Abstract][Full Text] [Related]
25. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase.
Han X; Kubota I; Feron O; Opel DJ; Arstall MA; Zhao YY; Huang P; Fishman MC; Michel T; Kelly RA
Proc Natl Acad Sci U S A; 1998 May; 95(11):6510-5. PubMed ID: 9600997
[TBL] [Abstract][Full Text] [Related]
26. Contrasting effects of isoproterenol and phosphodiesterase III inhibitor on intracellular calcium transients in cardiac myocytes from failing hearts.
Honda M; Kuramochi T; Ishinaga Y; Kuzuo H; Tanaka K; Morioka S; Enomoto K; Takabatake T
Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):1001-8. PubMed ID: 7736650
[TBL] [Abstract][Full Text] [Related]
27. Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization.
Sulakhe PV; Vo XT
Mol Cell Biochem; 1995; 149-150():103-26. PubMed ID: 8569720
[TBL] [Abstract][Full Text] [Related]
28. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.
Gauthier C; Leblais V; Kobzik L; Trochu JN; Khandoudi N; Bril A; Balligand JL; Le Marec H
J Clin Invest; 1998 Oct; 102(7):1377-84. PubMed ID: 9769330
[TBL] [Abstract][Full Text] [Related]
29. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture.
Ungureanu-Longrois D; Balligand JL; Okada I; Simmons WW; Kobzik L; Lowenstein CJ; Kunkel SL; Michel T; Kelly RA; Smith TW
Circ Res; 1995 Sep; 77(3):486-93. PubMed ID: 7543825
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells.
Han X; Kobzik L; Balligand JL; Kelly RA; Smith TW
Circ Res; 1996 Jun; 78(6):998-1008. PubMed ID: 8635250
[TBL] [Abstract][Full Text] [Related]
31. Regulation of calcium current by low-Km cyclic AMP phosphodiesterases in cardiac cells.
Fischmeister R; Hartzell HC
Mol Pharmacol; 1990 Sep; 38(3):426-33. PubMed ID: 1698253
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the cAMP-elevating effects of isoproterenol and forskolin in cardiac myocytes by treatments that cause increases in cAMP.
Cui H; Green RD
Biochem Biophys Res Commun; 2003 Jul; 307(1):119-26. PubMed ID: 12849990
[TBL] [Abstract][Full Text] [Related]
33. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory modulation by cAMP of isoproterenol-induced prostacyclin synthesis in rabbit heart.
Williams JL; Malik KU
Am J Physiol; 1989 Oct; 257(4 Pt 2):R771-80. PubMed ID: 2478036
[TBL] [Abstract][Full Text] [Related]
35. Developmental changes in modulation of calcium currents of rabbit ventricular cells by phosphodiesterase inhibitors.
Akita T; Joyner RW; Lu C; Kumar R; Hartzell HC
Circulation; 1994 Jul; 90(1):469-78. PubMed ID: 7517800
[TBL] [Abstract][Full Text] [Related]
36. beta 1-and beta 2-adrenergic receptors exhibit differing susceptibility to muscarinic accentuated antagonism.
Aprigliano O; Rybin VO; Pak E; Robinson RB; Steinberg SF
Am J Physiol; 1997 Jun; 272(6 Pt 2):H2726-35. PubMed ID: 9227552
[TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase III and V inhibitors on pulmonary artery from pulmonary hypertensive rats: differences between early and established pulmonary hypertension.
Jeffery TK; Wanstall JC
J Cardiovasc Pharmacol; 1998 Aug; 32(2):213-9. PubMed ID: 9700982
[TBL] [Abstract][Full Text] [Related]
38. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
39. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes.
Harbrecht BG; Taylor BS; Xu Z; Ramalakshmi S; Ganster RW; Geller DA
J Surg Res; 2001 Aug; 99(2):258-64. PubMed ID: 11469895
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
